The Latest Press Releases from Cancer Guardian and Wamberg Genomic Advisors

More Than One in Three Cancer Patients Wished They Had Their Own Dedicated Cancer Expert to Advocate on Their Behalf–Wamberg Genomic Survey

Wamberg Genomic Advisors’ Cancer Guardian, a Comprehensive Cancer Support Program, to Include the Color Clinical-Grade Genetic Test

47 Percent of Cancer Patients Said Most Troubling Part of Finding Treatment/Solution Was “No Knowledgeable Advocate to Help”–Wamberg Genomic Survey

David Stertzer, Advisor and Immediate Past CEO of AALU, Joins Wamberg Genomic Advisors as Managing Director

Wamberg Genomic Advisors Inks Partnership with National Benefit Partners to Distribute Cancer Guardian, a Comprehensive Cancer Support Program, to Employers as a new Employee Benefit

Wamberg Genomic Advisors Announces The Penn Mutual Life Insurance Company to Provide Cancer Guardian as a Benefit to its Associates

Wamberg Genomic Advisors Expands its Cancer Guardian™ Program to Include Comprehensive Cancer Support, led by Cancer Support Specialists, Medical Record Management, and Advanced DNA Testing

© 2018 Wamberg Genomic Advisors. All rights reserved. Privacy Policy |Terms and Conditions

Back to the top